Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection

Published: 01/08/2019

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

Lupin Pharmaceuticals, Inc. is voluntarily recalling the following to the hospital level:

  • Five (5) lots of Ceftriaxone for Injection, USP, 250mg
  • Ten (10) lots of Ceftriaxone for Injection, USP, 500mg
  • Twenty-four (24) lots of Ceftriaxone for Injection, USP, 1g
  • Three (3) lots of Ceftriaxone for Injection, USP 2g

The products have been found to contain visual grey particulate matter in reconstituted vials.

Improper piercing and use of a needle greater than 21 gauge, while reconstituting the v

Sign Up for Free Trial